Paper9860002
Reperfusion of occluded capillary beds in diabetic retinopathy.
Takahashi K and 3 others. Am J Ophthalmol, 1998. Cited by 47 papers, by iCite.
Cite this record
ConductScience Library. Reperfusion of occluded capillary beds in diabetic retinopathy. Papers, record 9860002. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/9860002
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Diabetic Retinopathy | Major topic |
| Retinal Artery Occlusion | Major topic |
| Retinal Vein Occlusion | Major topic |
| Retinal Vessels | Major topic |
| Adult | |
| Aged | |
| Capillaries | |
| Diabetes Mellitus, Type 2 | |
| Female | |
| Fluorescein Angiography | |
| Follow-Up Studies | |
| Fundus Oculi | |
| Humans | |
| Male | |
| Middle Aged | |
| Reperfusion | |
| Retinal Neovascularization | |
| Retrospective Studies |
Source PubMed
Cited by22
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42137619 | Recent Investigations on Pathogenesis, Biomarkers, Epigenetics, and Emerging Therapeutic Strategies to Modulate Multiple Signaling Pathways in Diabetic Retinopathy. | J Ophthalmol | 2026 | https://conductscience.org/library/papers/42137619 | PubMed |
| 40087728 | Chronic intermittent hypoxia disrupts protective microgliosis in ischemic proliferative retinopathy. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/40087728 | PubMed |
| 39834875 | Longitudinal evaluation of cotton wool spot following rapid glycemic improvement using wide-field multimodal imaging. | Am J Ophthalmol Case Rep | 2025 | https://conductscience.org/library/papers/39834875 | PubMed |
| 39786395 | The Effects of Anti-Vascular Endothelial Growth Factor Loading Injections on Retinal Microvasculature in Diabetic Macular Edema. | Transl Vis Sci Technol | 2024 | https://conductscience.org/library/papers/39786395 | PubMed |
| 37313218 | Assessment of a Novel Semi-Automated Algorithm for the Quantification of the Parafoveal Capillary Network. | Clin Ophthalmol | 2023 | https://conductscience.org/library/papers/37313218 | PubMed |
| 36983406 | Retinal Ischaemia in Diabetic Retinopathy: Understanding and Overcoming a Therapeutic Challenge. | J Clin Med | 2023 | https://conductscience.org/library/papers/36983406 | PubMed |
| 35907890 | Advances in cell therapies using stem cells/progenitors as a novel approach for neurovascular repair of the diabetic retina. | Stem Cell Res Ther | 2022 | https://conductscience.org/library/papers/35907890 | PubMed |
| 35017700 | Retinal non-perfusion in diabetic retinopathy. | Eye (Lond) | 2022 | https://conductscience.org/library/papers/35017700 | PubMed |
| 34902545 | Diabetic macular ischaemia- a new therapeutic target? | Prog Retin Eye Res | 2022 | https://conductscience.org/library/papers/34902545 | PubMed |
| 34408316 | Disentangling the association between retinal non-perfusion and anti-VEGF agents in diabetic retinopathy. | Eye (Lond) | 2022 | https://conductscience.org/library/papers/34408316 | PubMed |
| 33469209 | Current understanding of the molecular and cellular pathology of diabetic retinopathy. | Nat Rev Endocrinol | 2021 | https://conductscience.org/library/papers/33469209 | PubMed |
| 33299892 | Widefield Optical Coherence Tomography Angiography in Diabetic Retinopathy. | J Diabetes Res | 2020 | https://conductscience.org/library/papers/33299892 | PubMed |
| 33240272 | The Role of Inflammation in Diabetic Retinopathy. | Front Immunol | 2020 | https://conductscience.org/library/papers/33240272 | PubMed |
| 32514410 | Morphological changes in intraretinal microvascular abnormalities after anti-VEGF therapy visualized on optical coherence tomography angiography. | Eye Vis (Lond) | 2020 | https://conductscience.org/library/papers/32514410 | PubMed |
| 32191287 | A Proposed Classification of Intraretinal Microvascular Abnormalities in Diabetic Retinopathy Following Panretinal Photocoagulation. | Invest Ophthalmol Vis Sci | 2020 | https://conductscience.org/library/papers/32191287 | PubMed |
| 30068515 | Peripheral capillary non-perfusion in treatment-naïve proliferative diabetic retinopathy associates with postoperative disease activity 6 months after panretinal photocoagulation. | Br J Ophthalmol | 2019 | https://conductscience.org/library/papers/30068515 | PubMed |
| 28176934 | Retinal reperfusion in diabetic retinopathy following treatment with anti-VEGF intravitreal injections. | Clin Ophthalmol | 2017 | https://conductscience.org/library/papers/28176934 | PubMed |
| 24782825 | Endothelial progenitor cells in diabetic retinopathy. | Front Endocrinol (Lausanne) | 2014 | https://conductscience.org/library/papers/24782825 | PubMed |
| 24205223 | Antagonism of CD11b with neutrophil inhibitory factor (NIF) inhibits vascular lesions in diabetic retinopathy. | PLoS One | 2013 | https://conductscience.org/library/papers/24205223 | PubMed |
| 23275212 | Expounding newer vistas in VEGF. | Indian J Ophthalmol | 2013 | https://conductscience.org/library/papers/23275212 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/9860002
GET https://conductscience.org/api/papers/v1/9860002/cited_by?page=2